Global Active Pharmaceutical Ingredients (API) CDMO Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Active Pharmaceutical Ingredients (API) CDMO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Active Pharmaceutical Ingredients (API) CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Active Pharmaceutical Ingredients (API) CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Active Pharmaceutical Ingredients (API) CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Active Pharmaceutical Ingredients (API) CDMO players cover Recipharm, Cambrex Corporation, Patheon (Thermo Fisher Scientific), CordenPharma, Lonza, Siegfried, Catalent, Boehringer Ingelheim and Piramal Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Active Pharmaceutical Ingredients (API) CDMO Industry Forecast” looks at past sales and reviews total world Active Pharmaceutical Ingredients (API) CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Active Pharmaceutical Ingredients (API) CDMO sales for 2023 through 2029. With Active Pharmaceutical Ingredients (API) CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Active Pharmaceutical Ingredients (API) CDMO industry.
This Insight Report provides a comprehensive analysis of the global Active Pharmaceutical Ingredients (API) CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Active Pharmaceutical Ingredients (API) CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Active Pharmaceutical Ingredients (API) CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Active Pharmaceutical Ingredients (API) CDMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Active Pharmaceutical Ingredients (API) CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredients (API) CDMO market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Active Pharmaceutical Ingredients (API) CDMO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Active Pharmaceutical Ingredients (API) CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Active Pharmaceutical Ingredients (API) CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Active Pharmaceutical Ingredients (API) CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Active Pharmaceutical Ingredients (API) CDMO players cover Recipharm, Cambrex Corporation, Patheon (Thermo Fisher Scientific), CordenPharma, Lonza, Siegfried, Catalent, Boehringer Ingelheim and Piramal Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Active Pharmaceutical Ingredients (API) CDMO Industry Forecast” looks at past sales and reviews total world Active Pharmaceutical Ingredients (API) CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Active Pharmaceutical Ingredients (API) CDMO sales for 2023 through 2029. With Active Pharmaceutical Ingredients (API) CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Active Pharmaceutical Ingredients (API) CDMO industry.
This Insight Report provides a comprehensive analysis of the global Active Pharmaceutical Ingredients (API) CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Active Pharmaceutical Ingredients (API) CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Active Pharmaceutical Ingredients (API) CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Active Pharmaceutical Ingredients (API) CDMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Active Pharmaceutical Ingredients (API) CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredients (API) CDMO market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Macromolecular API
- Small Molecule API
- Clinical
- Commercial
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recipharm
- Cambrex Corporation
- Patheon (Thermo Fisher Scientific)
- CordenPharma
- Lonza
- Siegfried
- Catalent
- Boehringer Ingelheim
- Piramal Group
- AbbVie
- SGS Quay Pharmaceuticals
- Aenova Group
- Curia
- Sterling Pharma Solutions
- Eurofins CDMO
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2029
2.1.2 Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Active Pharmaceutical Ingredients (API) CDMO Segment by Type
2.2.1 Macromolecular API
2.2.2 Small Molecule API
2.3 Active Pharmaceutical Ingredients (API) CDMO Market Size by Type
2.3.1 Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
2.4 Active Pharmaceutical Ingredients (API) CDMO Segment by Application
2.4.1 Clinical
2.4.2 Commercial
2.4.3 Others
2.5 Active Pharmaceutical Ingredients (API) CDMO Market Size by Application
2.5.1 Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
3 ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO MARKET SIZE BY PLAYER
3.1 Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Players
3.1.1 Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Players (2018-2023)
3.1.2 Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Active Pharmaceutical Ingredients (API) CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO BY REGIONS
4.1 Active Pharmaceutical Ingredients (API) CDMO Market Size by Regions (2018-2023)
4.2 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
4.3 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
4.4 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
4.5 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Country (2018-2023)
5.2 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
5.3 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2023)
6.2 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
6.3 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Active Pharmaceutical Ingredients (API) CDMO by Country (2018-2023)
7.2 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
7.3 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO by Region (2018-2023)
8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO MARKET FORECAST
10.1 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Regions (2024-2029)
10.1.1 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Regions (2024-2029)
10.1.2 Americas Active Pharmaceutical Ingredients (API) CDMO Forecast
10.1.3 APAC Active Pharmaceutical Ingredients (API) CDMO Forecast
10.1.4 Europe Active Pharmaceutical Ingredients (API) CDMO Forecast
10.1.5 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Forecast
10.2 Americas Active Pharmaceutical Ingredients (API) CDMO Forecast by Country (2024-2029)
10.2.1 United States Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.2.2 Canada Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.2.3 Mexico Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.2.4 Brazil Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3 APAC Active Pharmaceutical Ingredients (API) CDMO Forecast by Region (2024-2029)
10.3.1 China Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.2 Japan Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.3 Korea Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.4 Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.5 India Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.6 Australia Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4 Europe Active Pharmaceutical Ingredients (API) CDMO Forecast by Country (2024-2029)
10.4.1 Germany Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.2 France Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.3 UK Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.4 Italy Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.5 Russia Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Forecast by Region (2024-2029)
10.5.1 Egypt Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.2 South Africa Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.3 Israel Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.4 Turkey Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.5 GCC Countries Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.6 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Type (2024-2029)
10.7 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Recipharm
11.1.1 Recipharm Company Information
11.1.2 Recipharm Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.1.3 Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Recipharm Main Business Overview
11.1.5 Recipharm Latest Developments
11.2 Cambrex Corporation
11.2.1 Cambrex Corporation Company Information
11.2.2 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.2.3 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cambrex Corporation Main Business Overview
11.2.5 Cambrex Corporation Latest Developments
11.3 Patheon (Thermo Fisher Scientific)
11.3.1 Patheon (Thermo Fisher Scientific) Company Information
11.3.2 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.3.3 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Patheon (Thermo Fisher Scientific) Main Business Overview
11.3.5 Patheon (Thermo Fisher Scientific) Latest Developments
11.4 CordenPharma
11.4.1 CordenPharma Company Information
11.4.2 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.4.3 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 CordenPharma Main Business Overview
11.4.5 CordenPharma Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.5.3 Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 Siegfried
11.6.1 Siegfried Company Information
11.6.2 Siegfried Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.6.3 Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Siegfried Main Business Overview
11.6.5 Siegfried Latest Developments
11.7 Catalent
11.7.1 Catalent Company Information
11.7.2 Catalent Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.7.3 Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Catalent Main Business Overview
11.7.5 Catalent Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.8.3 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Piramal Group
11.9.1 Piramal Group Company Information
11.9.2 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.9.3 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Piramal Group Main Business Overview
11.9.5 Piramal Group Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.10.3 AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
11.11 SGS Quay Pharmaceuticals
11.11.1 SGS Quay Pharmaceuticals Company Information
11.11.2 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.11.3 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SGS Quay Pharmaceuticals Main Business Overview
11.11.5 SGS Quay Pharmaceuticals Latest Developments
11.12 Aenova Group
11.12.1 Aenova Group Company Information
11.12.2 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.12.3 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Aenova Group Main Business Overview
11.12.5 Aenova Group Latest Developments
11.13 Curia
11.13.1 Curia Company Information
11.13.2 Curia Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.13.3 Curia Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Curia Main Business Overview
11.13.5 Curia Latest Developments
11.14 Sterling Pharma Solutions
11.14.1 Sterling Pharma Solutions Company Information
11.14.2 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.14.3 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Sterling Pharma Solutions Main Business Overview
11.14.5 Sterling Pharma Solutions Latest Developments
11.15 Eurofins CDMO
11.15.1 Eurofins CDMO Company Information
11.15.2 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.15.3 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Eurofins CDMO Main Business Overview
11.15.5 Eurofins CDMO Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2029
2.1.2 Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Active Pharmaceutical Ingredients (API) CDMO Segment by Type
2.2.1 Macromolecular API
2.2.2 Small Molecule API
2.3 Active Pharmaceutical Ingredients (API) CDMO Market Size by Type
2.3.1 Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
2.4 Active Pharmaceutical Ingredients (API) CDMO Segment by Application
2.4.1 Clinical
2.4.2 Commercial
2.4.3 Others
2.5 Active Pharmaceutical Ingredients (API) CDMO Market Size by Application
2.5.1 Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
3 ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO MARKET SIZE BY PLAYER
3.1 Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Players
3.1.1 Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Players (2018-2023)
3.1.2 Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Active Pharmaceutical Ingredients (API) CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO BY REGIONS
4.1 Active Pharmaceutical Ingredients (API) CDMO Market Size by Regions (2018-2023)
4.2 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
4.3 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
4.4 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
4.5 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Country (2018-2023)
5.2 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
5.3 Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2023)
6.2 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
6.3 APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Active Pharmaceutical Ingredients (API) CDMO by Country (2018-2023)
7.2 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
7.3 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO by Region (2018-2023)
8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO MARKET FORECAST
10.1 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Regions (2024-2029)
10.1.1 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Regions (2024-2029)
10.1.2 Americas Active Pharmaceutical Ingredients (API) CDMO Forecast
10.1.3 APAC Active Pharmaceutical Ingredients (API) CDMO Forecast
10.1.4 Europe Active Pharmaceutical Ingredients (API) CDMO Forecast
10.1.5 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Forecast
10.2 Americas Active Pharmaceutical Ingredients (API) CDMO Forecast by Country (2024-2029)
10.2.1 United States Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.2.2 Canada Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.2.3 Mexico Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.2.4 Brazil Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3 APAC Active Pharmaceutical Ingredients (API) CDMO Forecast by Region (2024-2029)
10.3.1 China Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.2 Japan Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.3 Korea Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.4 Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.5 India Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.3.6 Australia Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4 Europe Active Pharmaceutical Ingredients (API) CDMO Forecast by Country (2024-2029)
10.4.1 Germany Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.2 France Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.3 UK Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.4 Italy Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.4.5 Russia Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5 Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Forecast by Region (2024-2029)
10.5.1 Egypt Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.2 South Africa Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.3 Israel Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.4 Turkey Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.5.5 GCC Countries Active Pharmaceutical Ingredients (API) CDMO Market Forecast
10.6 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Type (2024-2029)
10.7 Global Active Pharmaceutical Ingredients (API) CDMO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Recipharm
11.1.1 Recipharm Company Information
11.1.2 Recipharm Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.1.3 Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Recipharm Main Business Overview
11.1.5 Recipharm Latest Developments
11.2 Cambrex Corporation
11.2.1 Cambrex Corporation Company Information
11.2.2 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.2.3 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cambrex Corporation Main Business Overview
11.2.5 Cambrex Corporation Latest Developments
11.3 Patheon (Thermo Fisher Scientific)
11.3.1 Patheon (Thermo Fisher Scientific) Company Information
11.3.2 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.3.3 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Patheon (Thermo Fisher Scientific) Main Business Overview
11.3.5 Patheon (Thermo Fisher Scientific) Latest Developments
11.4 CordenPharma
11.4.1 CordenPharma Company Information
11.4.2 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.4.3 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 CordenPharma Main Business Overview
11.4.5 CordenPharma Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.5.3 Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 Siegfried
11.6.1 Siegfried Company Information
11.6.2 Siegfried Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.6.3 Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Siegfried Main Business Overview
11.6.5 Siegfried Latest Developments
11.7 Catalent
11.7.1 Catalent Company Information
11.7.2 Catalent Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.7.3 Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Catalent Main Business Overview
11.7.5 Catalent Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.8.3 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Piramal Group
11.9.1 Piramal Group Company Information
11.9.2 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.9.3 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Piramal Group Main Business Overview
11.9.5 Piramal Group Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.10.3 AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
11.11 SGS Quay Pharmaceuticals
11.11.1 SGS Quay Pharmaceuticals Company Information
11.11.2 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.11.3 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SGS Quay Pharmaceuticals Main Business Overview
11.11.5 SGS Quay Pharmaceuticals Latest Developments
11.12 Aenova Group
11.12.1 Aenova Group Company Information
11.12.2 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.12.3 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Aenova Group Main Business Overview
11.12.5 Aenova Group Latest Developments
11.13 Curia
11.13.1 Curia Company Information
11.13.2 Curia Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.13.3 Curia Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Curia Main Business Overview
11.13.5 Curia Latest Developments
11.14 Sterling Pharma Solutions
11.14.1 Sterling Pharma Solutions Company Information
11.14.2 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.14.3 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Sterling Pharma Solutions Main Business Overview
11.14.5 Sterling Pharma Solutions Latest Developments
11.15 Eurofins CDMO
11.15.1 Eurofins CDMO Company Information
11.15.2 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product Offered
11.15.3 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Eurofins CDMO Main Business Overview
11.15.5 Eurofins CDMO Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Macromolecular API
Table 3. Major Players of Small Molecule API
Table 4. Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 7. Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 10. Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Player (2018-2023)
Table 12. Active Pharmaceutical Ingredients (API) CDMO Key Players Head office and Products Offered
Table 13. Active Pharmaceutical Ingredients (API) CDMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Active Pharmaceutical Ingredients (API) CDMO Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Regions (2018-2023)
Table 18. Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Country (2018-2023)
Table 22. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 24. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 26. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region (2018-2023)
Table 28. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 30. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 32. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Country (2018-2023)
Table 34. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 36. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Active Pharmaceutical Ingredients (API) CDMO
Table 45. Key Market Challenges & Risks of Active Pharmaceutical Ingredients (API) CDMO
Table 46. Key Industry Trends of Active Pharmaceutical Ingredients (API) CDMO
Table 47. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Recipharm Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 52. Recipharm Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 53. Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Recipharm Main Business
Table 55. Recipharm Latest Developments
Table 56. Cambrex Corporation Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 57. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 58. Cambrex Corporation Main Business
Table 59. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cambrex Corporation Latest Developments
Table 61. Patheon (Thermo Fisher Scientific) Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 62. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 63. Patheon (Thermo Fisher Scientific) Main Business
Table 64. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Patheon (Thermo Fisher Scientific) Latest Developments
Table 66. CordenPharma Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 67. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 68. CordenPharma Main Business
Table 69. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. CordenPharma Latest Developments
Table 71. Lonza Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 72. Lonza Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 73. Lonza Main Business
Table 74. Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Lonza Latest Developments
Table 76. Siegfried Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 77. Siegfried Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 78. Siegfried Main Business
Table 79. Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Siegfried Latest Developments
Table 81. Catalent Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 82. Catalent Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 83. Catalent Main Business
Table 84. Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Catalent Latest Developments
Table 86. Boehringer Ingelheim Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 87. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Piramal Group Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 92. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 93. Piramal Group Main Business
Table 94. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Piramal Group Latest Developments
Table 96. AbbVie Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 97. AbbVie Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 98. AbbVie Main Business
Table 99. AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. AbbVie Latest Developments
Table 101. SGS Quay Pharmaceuticals Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 102. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 103. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SGS Quay Pharmaceuticals Main Business
Table 105. SGS Quay Pharmaceuticals Latest Developments
Table 106. Aenova Group Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 107. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 108. Aenova Group Main Business
Table 109. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Aenova Group Latest Developments
Table 111. Curia Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 112. Curia Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 113. Curia Main Business
Table 114. Curia Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Curia Latest Developments
Table 116. Sterling Pharma Solutions Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 117. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 118. Sterling Pharma Solutions Main Business
Table 119. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Sterling Pharma Solutions Latest Developments
Table 121. Eurofins CDMO Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 122. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 123. Eurofins CDMO Main Business
Table 124. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Eurofins CDMO Latest Developments
Table 1. Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Macromolecular API
Table 3. Major Players of Small Molecule API
Table 4. Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 7. Active Pharmaceutical Ingredients (API) CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 10. Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Player (2018-2023)
Table 12. Active Pharmaceutical Ingredients (API) CDMO Key Players Head office and Products Offered
Table 13. Active Pharmaceutical Ingredients (API) CDMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Active Pharmaceutical Ingredients (API) CDMO Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Regions (2018-2023)
Table 18. Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Country (2018-2023)
Table 22. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 24. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 26. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region (2018-2023)
Table 28. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 30. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 32. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Country (2018-2023)
Table 34. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 36. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Active Pharmaceutical Ingredients (API) CDMO
Table 45. Key Market Challenges & Risks of Active Pharmaceutical Ingredients (API) CDMO
Table 46. Key Industry Trends of Active Pharmaceutical Ingredients (API) CDMO
Table 47. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Recipharm Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 52. Recipharm Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 53. Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Recipharm Main Business
Table 55. Recipharm Latest Developments
Table 56. Cambrex Corporation Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 57. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 58. Cambrex Corporation Main Business
Table 59. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cambrex Corporation Latest Developments
Table 61. Patheon (Thermo Fisher Scientific) Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 62. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 63. Patheon (Thermo Fisher Scientific) Main Business
Table 64. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Patheon (Thermo Fisher Scientific) Latest Developments
Table 66. CordenPharma Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 67. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 68. CordenPharma Main Business
Table 69. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. CordenPharma Latest Developments
Table 71. Lonza Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 72. Lonza Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 73. Lonza Main Business
Table 74. Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Lonza Latest Developments
Table 76. Siegfried Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 77. Siegfried Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 78. Siegfried Main Business
Table 79. Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Siegfried Latest Developments
Table 81. Catalent Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 82. Catalent Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 83. Catalent Main Business
Table 84. Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Catalent Latest Developments
Table 86. Boehringer Ingelheim Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 87. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Piramal Group Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 92. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 93. Piramal Group Main Business
Table 94. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Piramal Group Latest Developments
Table 96. AbbVie Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 97. AbbVie Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 98. AbbVie Main Business
Table 99. AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. AbbVie Latest Developments
Table 101. SGS Quay Pharmaceuticals Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 102. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 103. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SGS Quay Pharmaceuticals Main Business
Table 105. SGS Quay Pharmaceuticals Latest Developments
Table 106. Aenova Group Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 107. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 108. Aenova Group Main Business
Table 109. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Aenova Group Latest Developments
Table 111. Curia Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 112. Curia Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 113. Curia Main Business
Table 114. Curia Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Curia Latest Developments
Table 116. Sterling Pharma Solutions Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 117. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 118. Sterling Pharma Solutions Main Business
Table 119. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Sterling Pharma Solutions Latest Developments
Table 121. Eurofins CDMO Details, Company Type, Active Pharmaceutical Ingredients (API) CDMO Area Served and Its Competitors
Table 122. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product Offered
Table 123. Eurofins CDMO Main Business
Table 124. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Eurofins CDMO Latest Developments
LIST OF FIGURES
Figure 1. Active Pharmaceutical Ingredients (API) CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Active Pharmaceutical Ingredients (API) CDMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Active Pharmaceutical Ingredients (API) CDMO Sales Market Share by Country/Region (2022)
Figure 8. Active Pharmaceutical Ingredients (API) CDMO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type in 2022
Figure 10. Active Pharmaceutical Ingredients (API) CDMO in Clinical
Figure 11. Global Active Pharmaceutical Ingredients (API) CDMO Market: Clinical (2018-2023) & ($ Millions)
Figure 12. Active Pharmaceutical Ingredients (API) CDMO in Commercial
Figure 13. Global Active Pharmaceutical Ingredients (API) CDMO Market: Commercial (2018-2023) & ($ Millions)
Figure 14. Active Pharmaceutical Ingredients (API) CDMO in Others
Figure 15. Global Active Pharmaceutical Ingredients (API) CDMO Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application in 2022
Figure 17. Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Player in 2022
Figure 18. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 20. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 21. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 23. Americas Active Pharmaceutical Ingredients (API) CDMO Value Market Share by Country in 2022
Figure 24. United States Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region in 2022
Figure 29. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type in 2022
Figure 30. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application in 2022
Figure 31. China Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Country in 2022
Figure 38. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Figure 39. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Figure 40. Germany Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 54. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 55. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 57. United States Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 58. Canada Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 61. China Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 62. Japan Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 63. Korea Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 65. India Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 66. Australia Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 67. Germany Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 68. France Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 69. UK Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 70. Italy Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 71. Russia Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 72. Spain Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 75. Israel Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 78. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Active Pharmaceutical Ingredients (API) CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Active Pharmaceutical Ingredients (API) CDMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Active Pharmaceutical Ingredients (API) CDMO Sales Market Share by Country/Region (2022)
Figure 8. Active Pharmaceutical Ingredients (API) CDMO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type in 2022
Figure 10. Active Pharmaceutical Ingredients (API) CDMO in Clinical
Figure 11. Global Active Pharmaceutical Ingredients (API) CDMO Market: Clinical (2018-2023) & ($ Millions)
Figure 12. Active Pharmaceutical Ingredients (API) CDMO in Commercial
Figure 13. Global Active Pharmaceutical Ingredients (API) CDMO Market: Commercial (2018-2023) & ($ Millions)
Figure 14. Active Pharmaceutical Ingredients (API) CDMO in Others
Figure 15. Global Active Pharmaceutical Ingredients (API) CDMO Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application in 2022
Figure 17. Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Player in 2022
Figure 18. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 20. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 21. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size 2018-2023 ($ Millions)
Figure 23. Americas Active Pharmaceutical Ingredients (API) CDMO Value Market Share by Country in 2022
Figure 24. United States Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region in 2022
Figure 29. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type in 2022
Figure 30. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application in 2022
Figure 31. China Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Country in 2022
Figure 38. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Figure 39. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Figure 40. Germany Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Active Pharmaceutical Ingredients (API) CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 54. APAC Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 55. Europe Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 57. United States Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 58. Canada Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 61. China Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 62. Japan Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 63. Korea Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 65. India Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 66. Australia Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 67. Germany Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 68. France Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 69. UK Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 70. Italy Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 71. Russia Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 72. Spain Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 75. Israel Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Active Pharmaceutical Ingredients (API) CDMO Market Size 2024-2029 ($ Millions)
Figure 78. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share Forecast by Application (2024-2029)
